BioTime Expands OpRegen Clinical Trial In Dry-AMD With Opening Of First U.S. Sites Post author:Sam Post published:March 12, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Galera Therapeutics Doses First Patient in Pancreatic Cancer Trial February 27, 2018 GlaxoSmithKline Gets Expanded FDA Win for Fluarix January 11, 2018 CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation September 26, 2017
CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation September 26, 2017